Observational Study on Evaluation of Glycaemic Control in Patients Using a Modern Insulin - NovoRapid (Insulin Aspart), NovoMix 30 (Biphasic Insulin Aspart 30 [insulin aspart/insulin protamine aspart]) or Levemir (Insulin Detemir) for Treatment of Type 2 Diabetes Mellitus.

Trial Profile

Observational Study on Evaluation of Glycaemic Control in Patients Using a Modern Insulin - NovoRapid (Insulin Aspart), NovoMix 30 (Biphasic Insulin Aspart 30 [insulin aspart/insulin protamine aspart]) or Levemir (Insulin Detemir) for Treatment of Type 2 Diabetes Mellitus.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Oct 2016

At a glance

  • Drugs Insulin aspart; Insulin aspart/insulin protamine aspart; Insulin detemir
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 12 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top